Dietary changes to reduce gut bacteria's impact on heart health
Official title: Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)
Run by The Cleveland Clinic · NCT02016430 · Data updated 2026-11-12
This study is testing whether changing what people eat can lower a harmful compound linked to heart problems, specifically in those with high levels of it.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 170 (estimated) |
| Sponsor | The Cleveland Clinic Academic / other |
| Locations | 1 site (Cleveland, Ohio) |
| Status | Recruiting |
| Started | April 4, 2014 |
| Main results expected | December 2026 |
| Study ends | December 2026 |
| Registry record updated | June 25, 2026 |
| Trial ID | NCT02016430 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older with elevated TMAO levels or specific kidney function criteria.
✕Probably not a fit
Patients with normal TMAO levels or those unable to comply with dietary modifications may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot study explores how dietary interventions can influence the production of trimethylamine-N-oxide (TMAO), a compound linked to cardiovascular risk, by gut flora. Participants with elevated TMAO levels will undergo tailored dietary modifications to assess their effectiveness in reducing TMAO generation. The study will measure TMAO levels using stable-isotope-labelled nutrients and compare results between individuals with high and normal TMAO levels. The goal is to better understand the relationship between diet, gut bacteria, and cardiovascular health.
Why it matters
Potential benefit: If successful, this study could lead to dietary strategies that significantly lower cardiovascular risk by managing gut flora metabolism.
How similar studies have gone: Previous studies have indicated a potential link between diet and TMAO levels, suggesting this approach may yield beneficial results.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Cohort 1 Inclusion criteria: * Men and women age 18 years or above. * Elevated TMAO metabolizers (\>5 µM) based on screening test and/or eGFR \< 60 at most recent measurement. * Willing to remain on aspirin or able to be off aspirin or aspirin products for 1 week prior to starting the study and staying on the same aspirin regimen during the duration of the study. * Willing to sign the consent form and follow the study protocol, which includes a 12-week dietary modification. Cohort 2 Inclusion criteria: * Men and women age 18 years or above. * Willing to remain on aspirin or able to be off aspirin or aspirin products for 1 week prior to starting the study and staying on the same aspirin regimen during the duration of the study. * Willing to sign the consent form and follow the study protocol. * eGFR values ranging from 16-59 Cohort 3 Inclusion criteria: * Men and women age 18 years or above. * Willing to remain on aspirin or able to be off aspirin or aspirin products for 1 week prior to starting the study and staying on the same aspirin regimen during the duration of the study. * Willing to sign the consent form and follow the study protocol. Exclusion Criteria (all cohorts): * Significant chronic illness or end-organ dysfunction, including known history of uncompensated heart failure, renal failure, pulmonary disease, hematologic diseases. * Active infection or received antibiotics within 2 months of study enrollment * Use of over-the-counter probiotic within past month, or ingestion of yogurt within past 7 days * Having undergone bariatric procedures or surgeries such as gastric banding or bypass. * Pregnancy. * Any condition which, in the judgment of the Investigator, would place a patient at undue risk by being enrolled in the trial, or cause inability to comply with the trial
Where it's running
-
Cleveland Clinic
Cleveland, Ohio, United States Recruiting
Study contacts
- Principal investigator: W. H. Wilson Tang, MD — The Cleveland Clinic
- Study coordinator: Jennifer Wilcox, BA
- Email: kirsopj@ccf.org
- Phone: 216-636-6153
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
See if stopping alcohol can lower blood pressure and heart risk in adults who drink and have hypertension
This study tests whether abstaining from alcohol for 8 weeks can improve blood pressure and heart-health markers in adults who regularly drink and have high blood pressure.
-
AberTea: fermented seaweed English breakfast tea for heart and blood vessel health during menopause
This trial will test whether drinking three cups a day of AberTea (English breakfast tea enriched with fermented brown seaweed) for eight weeks can improve blood pressure and blood vessel function in postmenopausal women.
-
Adding fostemsavir to reduce inflammation in people with well-controlled HIV
This trial will test whether adding fostemsavir to current HIV treatment lowers inflammation and heart disease risk for people with well-controlled HIV who have detectable sgp120.
-
Preventive screening and health coaching for people facing food insecurity
A health coaching program delivered virtually is being tested to see if it lowers heart-disease risk and improves blood pressure, cholesterol, and diabetes markers in low-income adults who have limited access to food and healthcare.
-
Developing predictive risk models for pilots using advanced techniques
This study is trying to create personalized health risk models for high-performance pilots in the Italian Air Force to help keep them healthy and performing well in extreme conditions.
-
Investigating heart disease risk factors in psoriasis patients
This study is trying to see if certain heart-related markers can help predict heart disease risk in people with psoriasis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.